ARTICLE | Clinical News
Ameluz regulatory update
September 21, 2015 7:00 AM UTC
FDA accepted for review an NDA from Biofrontera for Ameluz and BF-RhodoLED to treat actinic keratosis. Ameluz is a photodynamic therapy (PDT) comprising nanoemulsion BF-200 with 5-aminolevulinic acid ...